FindTrial
Sign In

A clinical epidemiological study of genetic susceptibility in Chinese patients with primary cutaneous amyloidosis

A clinical epidemiological study of genetic susceptibility in Chinese patients with primary cutaneous amyloidosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014467
Enrollment
Unknown
Registered
2018-01-16
Start date
2018-01-31
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary cutaneous amyloidosis

Interventions

Case series:no

Sponsors

Dermatology Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Compliance with diagnostic criteria of PLCA

Exclusion criteria

Exclusion criteria: Exclusion of systemic amyloidosis

Design outcomes

Primary

MeasureTime frame
newly pathogenic genes;OSMR gene mutations rate;—

Countries

China

Contacts

Public ContactYang Bin

Dermatology Hospital, Southern Medical University

yangbin101@hotmail.com+86 13922207231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026